This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
Data set are available with author Akash Belenje and at ROP database office at LV Prasad Eye Institute, Hyderabad, Telangana, India-500034.
References
Vinekar A, Mangalesh S. Optical coherence tomography biomarkers in preterm infants with and without retinopathy of prematurity: fallacies and facts. EYE. 2024 [IN PRESS].
Belenje A, Reddy RU, Parmeswarappa DC, Padhi TR, Subbarao B, Jalali S. Evaluation of optical coherence tomography biomarkers to differentiate favourable and unfavourable responders to intravitreal anti-vascular endothelial growth factor treatment in retinopathy of prematurity. Eye (Lond). 2023. https://doi.org/10.1038/s41433-023-02824-1.
Mangalesh S, McGeehan B, Tai V, Chen X, Tran-Viet D, Vajzovic L, et al. Macular OCT characteristics at 36 weeks’ postmenstrual age in infants examined for retinopathy of prematurity. Ophthalmol Retin. 2021;5:580–92.
Furashova O, Matthè E. Hyperreflectivity of inner retinal layers as a quantitative parameter of ischemic damage in acute retinal vein occlusion (RVO): an Optical Coherence Tomography study. Clin Ophthalmol. 2020;14:2453–62. https://doi.org/10.2147/OPTH.S260000
Huang YT, Chang YC, Meng PP, Lin CJ, Lai CT, Hsia NY, et al. Optical coherence tomography biomarkers in predicting treatment outcomes of diabetic macular edema after dexamethasone implants. Front Med. 2022;9:852022 https://doi.org/10.3389/fmed.2022.852022
Vinekar A, Avadhani K, Sivakumar M, Mahendradas P, Kurian M, Braganza S, et al. Understanding clinically undetected macular changes in early retinopathy of prematurity on spectral domain optical coherence tomography. Investig Ophthalmol Vis Sci. 2011;52:5183–8.
Funding
Hyderabad Eye Research Foundation (2020), Hyderabad, India. The institute has received funding or support for its ongoing Retinopathy of Prematurity programs from Miriam Hyman Memorial Trust (MHMT, UK), Dalmia Holdings (India), Queen Elizabeth Diamond Jubilee Trust (UK), Public Health Foundation of India, Cognizant Foundation and the Government of India.
Author information
Authors and Affiliations
Contributions
Akash Belenje and Subhadra Jalali: wrote the reply to letter to editor, Devised and designed the study, devised data collection protocol and data analysis, literature search, and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
IRB approved with ethics number LEC-BHR-P-09-22-926.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Belenje, A., Jalali, S. Response to: Optical coherence tomography biomarkers in preterm infants with and without retinopathy of prematurity: fallacies and facts. Eye (2024). https://doi.org/10.1038/s41433-024-03062-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41433-024-03062-9